Durvalumab vs Moxifloxacin

## Durvalumab vs Moxifloxacin: Overview

This comparison examines the pharmacological differences between **Durvalumab** and **Moxifloxacin**.

## Mechanism of Action

**Durvalumab**: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

**Moxifloxacin**: Fourth-generation fluoroquinolone inhibiting DNA gyrase and topoisomerase IV with enhanced anaerobic activity.

## Pharmacokinetics

**Half-life**: Durvalumab — 17 days; Moxifloxacin — 12 hours.

## Chemical Properties

**Molecular Formula**: Durvalumab — N/A; Moxifloxacin — C21H24FN3O4.

**Molecular Weight**: Durvalumab — N/A; Moxifloxacin — 401.4350 g/mol.

**Type**: Durvalumab — Antibody; Moxifloxacin — Small molecule.